Clinical utility of clonal origin determination in managing recurrent hepatocellular carcinoma.

Shubham GuptaSikandar KhanMichal KawkaRohan GujjuriIan ChauNaureen StarlingDavid CunninghamLong R JiaoTamara Gall

Published in: Expert review of gastroenterology & hepatology (2021)

Improved identification of clonal origin in RHCC may facilitate further research on RHCC treatment strategies and enable the development of novel therapeutic targets, potentially leading to individualized treatment approaches in the future.

Keyphrases

current status
solid phase extraction
molecularly imprinted
combination therapy
bioinformatics analysis